Ischemia Care
Ischemia Care provides clinicians with a blood test that clarifies stroke cause so patients receive the right treatment faster. The company uses RNA expression profiling and machine learning in its ISCDx platform to distinguish major stroke etiologies, including cardioembolic strokes from atrial fibrillation. It operates a CLIA-certified laboratory and offers its solution as a laboratory-developed test with supporting software elements, backed by the BASE clinical trial of about 1,700 patients. The technology targets hospitals and stroke care clinicians to reduce readmissions, lower total cost of care, and prevent recurrent strokes.
Ischemia Care
Ischemia Care provides clinicians with a blood test that clarifies stroke cause so patients receive the right treatment faster. The company uses RNA expression profiling and machine learning in its ISCDx platform to distinguish major stroke etiologies, including cardioembolic strokes from atrial fibrillation. It operates a CLIA-certified laboratory and offers its solution as a laboratory-developed test with supporting software elements, backed by the BASE clinical trial of about 1,700 patients. The technology targets hospitals and stroke care clinicians to reduce readmissions, lower total cost of care, and prevent recurrent strokes.